Hi all,
I am analyzing ADNP expression in the Allen Human Brain Atlas (microarray dataset) and encountered a probe-level inconsistency that I would appreciate some guidance on.
Specifically, ADNP is represented by multiple probes in the AHBA. When I examined regional expression patterns (z-scored across brain regions, averaged across ~6 donors per region), I found that two probes show opposite trends within the same brain regions:
This discrepancy persists across multiple regions.
I am therefore trying to clarify:
-
What are the exact targets of these two probes?
- Do they map to different transcripts, exons, or UTRs of ADNP?
-
Is either probe known to have lower reliability, cross-hybridization, or weaker specificity for ADNP?
-
Is there an Allen-recommended probe for ADNP in the Human Brain Atlas (e.g. based on expression level, differential stability, or QC metrics)?
More generally, I would like to understand whether this divergence reflects biological transcript heterogeneity or is more likely a technical/annotation issue, and how best to handle this in downstream regional analyses.
Any guidance on probe selection or relevant documentation would be greatly appreciated.
